Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.

$371.9M

Market Cap • 5/9/2025

2000

(25 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Hollister

Headquarters • California